An observational study in Cardiovascular Diseases, sponsored by Karolinska Institutet. Status unknown. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-21.
Sponsored by Karolinska Institutet · Observational
To evaluate long-term effects of one individual- and population-oriented cardiovascular prevention programs in primary care.
In Sweden there are unique opportunities to create a relevant comparison group for this study, which is of great importance to the value of this cohort study.
Of the three study populations two (2-3)will be created by using national registries.
This three populations will be followed-up in national registries and databases
All subjects will be monitored for example disease history, socio-economics and biochemical risk factors presented below national registries and research databases. When all the matches of national registers and a local register (AMORIS)have been done the database will de-identified and anonymized data to be available for statistical processing.
5,025 studies on the registry are indexed under Cardiovascular Diseases; 930 are open to participants now.
This study's planned enrollment of 1,600,000 is above the median of 600 across 1,524 observational studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Karolinska Institutet is the lead sponsor of 1,146 studies on the registry; 275 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The screened group who participated in the cardiovascular prevention program:
(n=5938) and the rest of the population in Sollentuna Municipality.
Inclusion Criteria in the risk intervention group:
Exclusion Criteria in the screened intervention group:
Screened group is defined as those individuals who were willing to participate in the cardiovascular prevention program and all the individuals who lived in Sollentuna during the intervention.
Relatives to individuals included in the screened group, who lived in Stockholm County at least during one year at the time of the intervention.
Matched "controls" is going to be selected randomly from the population of Stockholm County minus Sollentuna Municipality with relevant background factors. The whole population will be used as a comparison group when evaluating the result from all the municipality of Sollentuna during 1988-1993.
Incidence and mortality in acute myocardial infarction, stroke, cardiovascular disease, and overall mortality, a twenty year follow-up of a prevention program.
Long term follow-up of a cardiovascular prevention program by using Swedish national patient registries
Time frame: 24 years
A follow-up of drug treatment of diabetes, dyslipidemia and hypertension
By using the drug register in Sweden do a follow-up of drug treatment in the cohort
Time frame: 24 years
Incidence and mortality in cancer
Incidence and mortality in cancer - a twenty year follow-up by using the swedish cancer register
Time frame: 24 years
Consumption of medical care overall and for different diagnostic groups
To study medical care consumption overall for different diagnostic groups by using different registers in Sweden
Time frame: 24 years
Health economic aspects
Health economic aspects such as 1. health care consumption in total and for different diagnostic groups 2. care costs 3. impact on indirect costs (lost working years and sick leave) 4. intervention cost will be studied
Time frame: 24 years
Time trends of morbidity and mortality in acute myocardial infarction, stroke, cardiovascular disease and total mortality
To study time trends of morbidity and mortality in acute myocardial infarction, stroke, cardiovascular disease and total mortality by use of National Swedish registries.
Time frame: 24 years
No study locations are listed for this record.
This study is status unknown, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.